Ann: COVID ARDS Trial Topline 60-Day Results, page-368

Hi,
The Shade throwers are irrelevant from here.
All the BS is over as we have now proven thanks to Eric Rose and the NIH
that the cells work.

Ive never doubted that this ARDS trial would prove successful as all other similar trials have had the same result .

Now its all about manufacture to bring treatment prices down.

Holders after bank rolling Mesoblast for a Decade can finally make a healthy
return.

$3.00 by weeks end . Years end who knows $20.00 ???

PS did you see the volume with a 20% price increase with MESO the other nite.
This stock is about to go up big time still 6% shorted. Beautiful.

Aloha.